Ab initio structure determination of 3,4-diaminopyridin-1-ium dihydrogen phosphate

Powder Diffraction

Volumn 26, Issue 4, 2011, Pages 321-325

  Le Bail, A ^a   Smrcok L ^b  

^a UNIVERSITÉ DU MAINE   (France)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

3,4 diaminopyridine; Ab initio; Crystal structure; DFT; Dihydrogen phosphate; Lambert Eaton myasthenic syndrome; Powder diffraction

Indexed keywords

EID: 84555217921     PISSN: 08857156     EISSN: 19457413     Source Type: Journal    
DOI: 10.1154/1.3660160     Document Type: Article

References (36)

1. Balamurugan P. Jagan R. Sivakumar K. Dihydrogen phosphate mediated supramolecular frameworks in 2- and 4-chloroanilinium dihydrogen phosphate salts. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2010, 66:o109-o113. 10.1107/S0108270110001940/gd3320sup1.cif.
2. 4 molecules in crystals. Acta Crystallogr. Sect. B: Struct. Sci. 1988, 44:334-340. 10.1107/S0108768188001429.
3. Blöchl P.E. Projector augmented-wave method. Phys. Rev. 1994, 50:17953-17979. 10.1103/PhysRevB.50.17953.
4. Demir S. Yilmaz V.T. Harrison W.T. A. 2-(Hydrogenmethyl) pyridinium dihydrogenphosphate. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2003, 59:o378-o380. 10.1107/S0108270103011077.
5. de Wolf P.M. simplified criterion for the reliability of powder pattern indexing. J. Appl. Crystallogr. 1968, 1:108-113. 10.1107/S002188986800508X.
6. Fun H.-K. Balasubramani K. 3,4-Diaminopyridinium hydrogen succinate. Acta Crystallogr., Sect. E: Struct. Rep. Online 2009, 65:o1531-o1532. 10.1107/S1600536809021205/sj2630sup1.cif.
7. Gražulis S. Chateigner D. Downs R.T. Yokochi A.F. T. Quirós M. Lutterotti L. Manakova E. Butkus J. Moeck P. Le Bail A. Crystallography Open Database an open-access collection of crystal structures. J. Appl. Crystallogr. 2009, 42:726-729. 10.1107/S0021889809016690.
8. Guyon F. Pradeau D. Le Hoang M.D. Houri J.-J. 2002, and International Patent No. WO2002062760 (15 August).
9. Jeffrey G.A. An Introduction to Hydrogen Bonding 1997, 12. (Oxford University Press, New York)
10. Kaman O. Smrčok L. Císařová I. Havlíček D. Dihydrogen phosphate and hydrogen sulphate of 1,4-dimethyl-1,4-diazabicyclo[2.2.2]octane-1,4-diium: Crystal structures, hydrogen bonding and infrared spectra. J. Chem. Crystallogr. 2011, 41:1539-1546. 10.1007/s10870-011-0137-0.
11. Koleva B. Tsanev T. Kolev T. Mayer-Figge H. Sheldrick W.S. 3,4-diaminopyridinium hydrogen squarate. Acta Crystallogr., Sect. E: Struct. Rep. Online 2007, 63:o3556. 10.1107/S1600536807031170/bt2412sup1.cif.
12. Koleva B. Kolev T. Tsanev T. Kotov S. Mayer-Figge H. Seidel R.W. Sheldrick W.S. Spectroscopic and structural elucidation of 3,4-diaminopyridine and its hydrogentartarate salt: Crystal structure of 3,4-diaminopyridinium hydrogentartarate dihydrate. J. Mol. Struct. 2008, 881:146-155. 10.1016/j.molstruc.2007.09.006.
13. Kresse G. Furthmüller J. Efficient iterative scheme for ab initio total energy calculations using plane-wave basis set. Phys. Rev. 1996a, 54:11169-11186. 10.1103/PhysRevB.54.11169.
14. Kresse G. Furthmüller J. Efficiency of ab-initio total energy calculations for metals and semiconductors using plane-wave basis set. Comput. Mater. Sci. 1996b, 6:15-50. 10.1016/0927-0256(96)00008-0.
15. Kresse G. Hafner J. Ab initio molecular dynamics for open-shell transition metals. Phys. Rev. 1993, 48:13115-13118. 10.1103/PhysRevB.48.13115.
16. Kresse G. Hafner J. Norm-conserving and ultrasoft pseudopotentials for first-row and transition elements. J. Phys.: Condens. Matter 1994, 6:8245-8527. 10.1088/0953-8984/6/40/015.
17. Kresse G. Joubert J. From ultrasoft potentials to the projector augmented wave method. Phys. Rev. 1999, 59:1758-1775. 10.1103/PhysRevB.59.1758.
18. Kumara Swamy K.C. Kumaraswamy S. Kommana P. Very strong C-H...O, N-H...O, and O-H...O hydrogen bonds involving cyclic phosphate. J. Am. Chem. Soc. 2001, 123:12642-12643. 10.1021/ja010713x.
19. Le Bail A. ESPOIR: program for solving structures by Monte Carlo from powder diffraction data. Mater. Sci. Forum 2001, 378-381:65-70. 10.4028/www.scientific.net/MSF.378-381.65.
20. Le Bail A. Monte Carlo indexing with MCMAILLE. Powder Diffr. 2004, 19:249-254. 10.1154/1.1763152.
21. Le Bail A. Whole powder pattern decomposition methods and applications-A retrospection. Powder Diffr. 2005, 20:316-326. 10.1154/1.2135315.
22. Le Bail A. Structure solution. Principles and Applications of Powder Diffraction 2008, 261-309. A. Clearfield, J. Reibenspies, N. Bhuvanesh in edited by and (Wiley, New York)
23. Le Bail A. Cranswick L.M. D. Adil K. Altomare A. Avdeev M. Cerny R. Cuocci C. Giacovazzo C. Halasz I. Lapidus S.H. Louwen J.N. Moliterni A. Palatinus L. Rizzi R. Schilder E.C. Stephens P.W. Stone K.H. van Mechelen J. Third structure determination by powder diffractometry round robin (SDPDRR-3). Powder Diffr. 2009, 24:254-262. 10.1154/1.3200881.
24. Mahmoudkhani A.H. Langer V. Phenylphosphonic acid as a building block for two-dimensional hydrogen-bonded supramolecular array. J. Mol. Struct. 2002, 609:97-108. 10.1016/S0022-2860(01)00954-1.
25. Marouani H. Al-Deyab S.S. Rzaigui M. 2-Aminopyrimidinium dihydrogen phosphate monohydrate. Acta Crystallogr., Sect. E: Struct. Rep. Online 2011, 67:o970-o971. 10.1107/S1600536811010658/pv2399sup1.cif.
26. McEvoy K.M. Windebank A.J. Daube J.R. Low P.A. 2,4-Diaminopyridine in the treatment of Lambert-Eaton mysathenic syndrome. N. Engl. J. Med. 1989, 321:1567-1571. 10.1056/NEJM198912073212303.
27. Perdew J.P. Wang Y. Accurate and simple analytic representation of the electron-gas correlation energy. Phys. Rev. 1992, 45:13244-13249. 10.1103/PhysRevB.45.13244.
28. Quartel A. Turbeville S. Lounsbury D. Current therapy for Lambert-Eaton myasthenic syndrome: Development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Curr. Med. Res. Opin. 2010, 26:1363-1375. 10.1185/03007991003745209.
29. Rietveld H.M. profile refinement method for nuclear and magnetic structures. J. Appl. Crystallogr. 1969, 2:65-71. 10.1107/S0021889869006558.
30. Rodriguez-Carvajal J. Recent advances in magnetic-structure determination by neutron powder diffraction. Physica 1993, 192:55-69. 10.1016/0921-4526(93)90108-I.
31. Rubin-Preminger J.M. Englert U. 3,4-Diaminopyridine. Acta Crystallogr., Sect. E: Struct. Rep. Online 2007, 64:o757-o758. 10.1107/S1600536807001444/bt2244sup1.cif.
32. Sheldrick G. short history of SHELX. Acta Crystallogr., Sect. A: Found. Crystallogr. 2008, 64:112-122. 10.1107/S0108767307043930.
33. Smith G.S. Snyder R.L. FN: criterion for rating powder diffraction patterns and evaluating the reliability of powder-pattern indexing. J. Appl. Crystallogr. 1979, 12:60-65. 10.1107/S002188987901178X.
34. Smrčok T. Havlíček D. Kaman O. Rundlof H. 1,4-Diazabicyclo[2.2.2]octane-1,4-diium dihydrogenphosphate monohydrate from X-ray and neutron data. Z. Kristallogr. 2009, 224:174-178. 10.1524/zkri.2009.1127.
35. Spek A.L. Single crystal structure validation with the program PLATON. J. Appl. Crystallogr. 2003, 36:7-13. 10.1107/S0021889802022112.
36. See supplementary material at E-PODIE2-26-011104 for the crystallographic information file (CIF).